News Center

Home page

Peak Report

News reports

Pharmaceutical companies to promote the production and sales of Chinese herbal pieces

Release time:

2022-12-13

walked into the traditional Chinese medicine decoction pieces workshop of Jinhua pharmaceutical company. the air was full of strong flavor of traditional Chinese medicine. the cooking machine "poop-poop " in the cooking room was steaming. the staff in charge of the care came to check the production situation from time to time. In the washing room, the machinery and equipment have just been cleaned, waiting for the next batch of medicinal materials "patronage " , several employees cooperate with tacit understanding, skillfully put Chinese herbal medicine into packaging bags, weighing, sealing, packing and storing in the warehouse, waiting to be shipped to the market ...... This is the production of Chinese herbal medicine workshop normal.

In the past two years, the sales volume and production orders of Chinese herbal pieces of pharmaceutical companies have increased significantly. In order to ensure that all orders of Chinese herbal pieces can be completed with good quality and quantity, the front-line production workers are working at full capacity and working overtime to put into production. Due to space constraints, the Chinese herbal medicine workshop arranges up to three different varieties of Chinese medicine production at a time, interspersed with processing procedures such as cleaning, slicing, drying, sterilization, packaging and storage. The weekly business department of the workshop receives orders for production and scheduling. The production volume of 16-20 tons of Chinese herbal pieces should be completed in one month, reaching 90 tons in one month at most. The production workshop is busy with production. When the business and storage personnel are tight, the pharmaceutical company also organizes logistics personnel to help ensure the on-time delivery of orders.

"The implementation of the new policy of no more than 25% of Chinese herbal pieces has not only reduced the medical expenses of patients, effectively guided the masses to choose more Chinese medicine services, but also promoted the concept of high quality and good price of Chinese herbal pieces. Wu Weisheng, general manager of " Pharmaceutical Company, said that on the 28th of June 1# this year, the "Implementation Opinions of Zhejiang Medical Security Bureau on Supporting the Inheritance and Innovation of Traditional Chinese Medicine" was formally implemented. Zhejiang Province required public medical institutions to strictly implement the bonus policy of increasing 25% sales according to the actual purchase price. The prices of Chinese herbal pieces in many places have dropped significantly, medical institutions pay more attention to the quality of drugs when purchasing Chinese herbal pieces. With the help of this policy change, pharmaceutical companies further optimize the suppliers of raw medicinal materials and purchase raw materials on the premise of high quality and good price. Every process in the production process is very strict. In addition to the on-site follow-up by the quality inspection personnel, each batch of traditional Chinese medicine produced is sent to the quality inspection center for inspection to ensure the quality of each batch of medicinal materials and give full play to the curative effect of medicinal materials. so that people can use conscience medicine, rest assured medicine and fine medicine anytime and anywhere. The high quality of products naturally drives the increase of sales volume. The output of Chinese herbal medicine workshop has also increased significantly compared with the same period last year, and the market development has also reached a new high. This year, the pharmaceutical company successfully broke through from

suppliers of traditional Chinese medicine and became one of 2 suppliers of Jinhua Hospital of Traditional Chinese Medicine. The sales volume directly doubled from the original small proportion. 4# Starting in 39, the bid for the distribution right of Chinese herbal pieces of medical institutions in Pan 'an County was won. , distribution bidding for township hospitals in Wucheng District, the pharmaceutical company ranked first in the distribution enterprise in terms of qualification, service and sample quality. The sales volume of Chinese herbal pieces in a hospital in Yongkang has also doubled this year. The relevant person in charge of the Chinese medicine department of the pharmaceutical company said that the increase in production capacity and sales, with sales, not only ensures product quality, but also reduces procurement costs to a certain extent, forming a healthy development of production and sales. Wu Weisheng said that at present, the traditional Chinese medicine decoction pieces business of pharmaceutical companies includes production and trade, with both self-operated varieties and OEM products. Next, pharmaceutical companies will also give full play to their advantages, adjust the industrial structure, and make every effort to promote the production and sales of Chinese herbal pieces according to the actual production of enterprises.

(Reporter

Ni Yingzhen)

More information

Daye Peak Opens "Standard Year"

After the 2019 overhaul ended in early March, Daye Jianfeng Cement Company immediately launched the "Standard Year" activity to carry out standardized rectification in view of a series of defects and problems in the daily management process. The goal of the "Standard Year" activity is to target specific issues that affect employees' work efficiency and safe and environmentally friendly production. Through the formulation of institutionalized work standards, further standardize employees' various operations, improve operational efficiency, and improve grassroots management execution, so as to achieve The purpose of improving the company's image, reducing costs, improving efficiency, and increasing benefits. In order to ensure the smooth progress of the activities, daye peak has set up a promotion team headed by general manager Zhang fengliang to be responsible for the overall promotion of the "standard year" activities, mainly including revising the activity plan, summarizing the standardized implementation standards of various departments, implementing the plan, supervising the implementation progress, evaluating the implementation effect, collecting suggestions and opinions in the implementation process, etc. Based on the foundation, aiming at the details and solving problems is a major feature of Daye peak's "standard year" activity. For example, the "Flange Sealing Operation Standard", which is currently being tried out, not only puts forward standardization requirements for such a "trivial matter" in equipment management as flange sealing, but also attaches "model" photos to make it clear to mechanics What should be done and what should be done. However, this "small standard" aims at three problems: leakage at the production site, extensive mechanic work and waste of materials. Once it becomes the behavior habit of employees, the hygiene and cost control at the production site are bound to be improved. It is understood that Daye peak "standard year" activities plan to continue for three years to promote, activities

2020

07-30

Shanghai North Carolina Jointly Builds Dongto Pharmaceutical Ecological Circle

News from our newspaper On the afternoon of March 26, the "2019 Dongzhi Pharmaceutical Industry Development Forum" co-sponsored by the Pharmaceutical Finance Circle and Shanghai Beika Pharmaceutical Technology Co., Ltd. was held in Dongzhi County, Anhui Province. More than 40 pharmaceutical industry entrepreneurs gathered together., To provide advice and suggestions for the future development of the pharmaceutical industry in Dongzhi County. At present, the pharmaceutical finance circle is an industry organization with certain influence in the field of biomedicine in China. It brings together high-end pharmaceutical industry elites and biomedical enterprises, and is committed to building a pharmaceutical industry ecosystem. With the concept of "co construction, co creation, win-win and sharing", it solves the common key problems of projects, capital and talents in the development of biomedicine, and forms a new ecology in the field of enterprise services. "2019 Dongzhi Pharmaceutical Industry Development Forum" is an important part of the "Anhui Business Investigation Tour" organized by Shanghai Beika and Pharmaceutical Finance Circle. On the morning of the 26th, the delegation visited New North Card Chemical, Zhongwang Pharmaceutical and other enterprises. Lou Xiaohua, executive deputy general manager of North Carolina Company, introduced the current development status of the company, the complete equipment and facilities and standardized management of the two companies, and the business philosophy of technological innovation as the core and "concentration, conscience, and anti-tumor leader" as its own responsibility. It was unanimously affirmed by the members of the delegation. Before the official start of the forum, Huang Jinlong, deputy general manager of the group company and general manager of Jianfeng Pharmaceutical, delivered a speech on behalf of Jianfeng Group, expressing gratitude to the county party committee and county government for the support of the "Dongzhi Pharmaceutical Development Forum" and to all the entrepreneurs who attended the meeting. Welcome, and give a brief introduction to why Jianfeng Group chose to invest in Dongzhi, and invite all colleagues to join in the development of Dongzhi medicine. In academic exchanges,

2020

07-31

Daye Peak Opens "Standard Year"

2020

07-31

Guizhou Huangping Cement Project Started

The expansion of the peak cement industry has taken substantial steps. A few days ago, the opening ceremony of the peak Guizhou Huangping cement project was held in Gulong Town, Huangping County. Huangping County is located in the southeast of Guizhou Province and the northwest of Qiandongnan Miao and Dong Autonomous Prefecture. It is rich in barite, limestone, gypsum, bauxite, mercury and other mineral resources. At the end of 2018, the board of directors of the group company passed the proposal to acquire all the shares of Guizhou Mingchuan company. After the acquisition is completed, Mingchuan Company will become a wholly-owned subsidiary of Jianfeng and will continue to invest about 0.65 billion yuan to build a new dry cement production line with a daily output of 4500 tons of cement clinker in an off-site technological transformation project (with waste heat power generation). On February 28, 2019, the Company and the former shareholders of Mingchuan completed the relevant asset transfer, equity transfer and industrial and commercial change registration procedures. Before the Spring Festival, the preparatory team with Hu Hongwei as the team leader and Lu Hongzheng as the deputy team leader has been stationed at the project site to carry out a series of preparatory work. The Huangping cement project is an important measure to strengthen the development of the company's main business according to the company's strategic policy of "strengthening the main business through cooperation and innovation, standardizing science and seeking development. The construction of the project will strictly follow the requirements of new industrialization, adopt advanced new dry-process rotary kiln production technology and industrial waste slag comprehensive utilization technology, which will not only bring economic and social benefits to the local area, but also further expand the scale of peak cement business. Become a new profit growth point of the company. Yu Jianhong, general manager of the group company, Huang Jinlong, deputy general manager, Zhu Jianwei, secretary of the board of directors, personnel of the preparation team of Huangping cement project, relevant leaders of Huangping County and Gulong Town, and person in charge of the project construction unit participated in the construction.

2020

07-31

Company fully deploys 2019 work

On January 28, the group company held a business analysis meeting to review and summarize the work situation in 2018, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2018, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2019. Xiang Chongping, deputy general manager of the group company, made a systematic review of the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control, safety and environmental protection work in 2018. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2018 and made a comparative analysis of the main economic indicators of each industrial sector. In 2018, the operating indicators of the company's various industrial sectors have improved significantly year-on-year, and the group company has also created the best operating performance in history. All units have completed the formulation of the second round of "three-year business plan", which points out the direction for the next three years of business work; the group company has also completed the first draft of the new "five-year strategic development plan", which is being revised and enriched. In addition, the two main businesses have also made substantial progress in investment expansion and industrial integration around strategic objectives, and the operating costs of major enterprises have decreased to varying degrees; the optimization of organizational structure and post setting has achieved new results, and management efficiency and people

2020

07-31

Company fully deploys 2019 work

2020

07-30

< 1...32 33 34...61 > 跳转到页